Get all your news in one place.

100’s of premium titles.
One app.

Start reading

Get all your news in one place.

100’s of premium titles. One news app.

Start reading

The Latest Breaking News from Cerevel rapeutics Hldg

Benzinga's Top Ratings Upgrades, Downgrades For September 26, 2022

Upgrades

Benzinga

Cerevel Therapeutics: Q1 Earnings Insights

Cerevel Therapeutics Hldg (NASDAQ:CERE) reported its Q1 earnings results on Tuesday, May 10, 2022 at 06:30 AM. Here's what investors need to know about the announcement.

Benzinga

Cerevel Therapeutics Hldg's Earnings: A Preview

Cerevel Therapeutics Hldg (NASDAQ:CERE) is set to give its latest quarterly earnings report on Tuesday, 2022-03-01. Here's what investors need to know before the announcement. Analysts estimate that Cerevel Therapeutics Hldg will report an earnings per share (EPS) of $-0.41.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Neurocrine Biosciences

American Rebel Holdings

10 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.